Immunome Inc Financial Flexibility Index
Immunome Inc financial flexibility index. Immunome Inc (IMNM) has a Financial Flexibility Index of -1.48x as of June 2026. Free cash flow of $-59.52 Million (operating CF $-61.69 Million minus capex $2.18 Million) represents -1% of total liabilities ($40.30 Million). Explore Immunome Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Immunome Inc (2018–2025)
Financial flexibility index of Immunome Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Immunome Inc across 8 annual periods. Check cash flow reinvestment rate of Immunome Inc to assess the company's total reinvestment commitment from operating cash flow.
Immunome Inc Financial Flexibility Index by Year (2018–2025)
Immunome Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Immunome Inc. For the full cash flow conversion analysis, see IMNM cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.71x | $-181.23 Million | $-190.92 Million | $48.84 Million | ▼ -282.6% |
| 2024 | -0.97x | $-57.29 Million | $-110.79 Million | $59.08 Million | ▼ -312.5% |
| 2023 | -0.24x | $-6.74 Million | $-7.57 Million | $28.66 Million | ▲ +93.9% |
| 2022 | -3.85x | $-28.44 Million | $-28.69 Million | $7.39 Million | ▼ -106.5% |
| 2021 | -1.86x | $-18.15 Million | $-18.23 Million | $9.74 Million | ▲ +48.7% |
| 2020 | -3.63x | $-11.55 Million | $-12.13 Million | $3.18 Million | ▼ -1477.5% |
| 2019 | -0.23x | $-9.37 Million | $-9.60 Million | $40.69 Million | ▲ +4.9% |
| 2018 | -0.24x | $-7.18 Million | $-7.41 Million | $29.65 Million | — |